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Randomized Controlled Trial of Social Media: Effect of Increased
Intensity of the Intervention
Caroline S. Fox, MD, MPH; Ellen B. Gurary, MSP; John Ryan, MD; Marc Bonaca, MD, MPH; Karen Barry, MS; Joseph Loscalzo, MD, PhD;
Joseph Massaro, PhD
Background-—A prior randomized controlled trial of social media exposure at Circulation determined that social media did not
increase 30-day page views. Whether insufﬁcient social media intensity contributed to these results is uncertain.
Methods and Results-—Original article manuscripts were randomized to social media exposure compared with no social media
exposure (control) at Circulation beginning in January 2015. Social media exposure consisted of Facebook and Twitter posts on the
journal’s accounts. To increase social media intensity, a larger base of followers was built using advertising and organic growth,
and posts were presented in triplicate and boosted on Facebook and retweeted on Twitter. The primary outcome was 30-day page
views. Stopping rules were established at the point that 50% of the manuscripts were randomized and had 30-day follow-up to
compare groups on 30-day page views. The trial was stopped for futility on September 26, 2015. Overall, 74 manuscripts were
randomized to receive social media exposure, and 78 manuscripts were randomized to the control arm. The intervention and
control arms were similar based on article type (P=0.85), geographic location of the corresponding author (P=0.33), and whether
the manuscript had an editorial (P=0.80). Median number of 30-day page views was 499.5 in the social media arm and 450.5 in the
control arm; there was no evidence of a treatment effect (P=0.38). There were no statistically signiﬁcant interactions of treatment
by manuscript type (P=0.86), by corresponding author (P=0.35), by trimester of publication date (P=0.34), or by editorial status
(P=0.79).
Conclusions-—A more intensive social media strategy did not result in increased 30-day page views of original research. ( J Am
Heart Assoc. 2016;5:e003088 doi: 10.1161/JAHA.115.003088)
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M any medical journals use social media strategies.Social media metrics, known as altmetrics, can be
used to predict the future impact of a manuscript1–4; however,
it remains unclear whether social media exposure itself can
serve as a driver of manuscript impact.
We previously conducted a randomized controlled trial at
the journal Circulation to test whether social media exposure
could increase the number of times an original article was
viewed.5 There was no difference between the control and
intervention groups. The trial, however, was limited by the
journal’s relatively small social media following at the time of
the clinical trial. Consequently, it was unclear whether these
ﬁndings could be generalizable to journals with larger social
media followings or those using more intensive social media
strategies.
We augmented the design of our initial study and
recapitulated our randomized controlled trial of social media
exposure at Circulation. This time, a higher intensity of social
media was used, including a larger social media following,
triplicate posting, retweeting, and the boosting of posts
to gain farther reach. In this paper, we report on these
ﬁndings.
Methods
Overall Design
This study was a randomized controlled trial of original articles
published in Circulation from January 13, 2015, through
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September 22, 2015. To differentiate ourselves from our prior
trial and to overcome a key limitation of the size of our
following during that trial, we actively built a larger base of
followers using advertising and capitalizing on the publicity
garnered from our ﬁrst trial. In the speciﬁed time period, 192
original articles were published. Articles were excluded if they
had a press release through the American Heart Association
or were designated as Circulation author proﬁles, resulting in
152 articles that were ultimately randomized. Randomization
to intervention or control occurred in a block size of 4 using
envelope randomization. The overall design is presented in
Figure 1.
Intervention
The primary intervention consisted of exposure of original
articles on Circulation’s Facebook (https://www.facebook.-
com/Circulation) and Twitter (@CircAHA) accounts. Posts
were written in clear English, included a key ﬁgure or image if
possible, and appeared online Monday through Thursday to be
contemporaneous with the publication of the articles. All
posts contained a toll-free link to the full-text version of the
manuscript on the Circulation website. Examples of posts are
as follows: (1) “Race, #SES, and life expectancy after #AMI—
read our new outcomes study here”; (2) “Meta-analysis of
>1 million pts demonstrates similar clinical outcomes for
#PCI centers w/on versus off-site surgery”; (3) “There is
#genetic overlap btwn #Alzheimers, #CRP & #lipids that can
help uncover novel #AD loci.” The comprehensive list of posts
can be viewed by visiting the sites. Other content included in
Circulation such as weekly images, review articles, clinician
updates, and guidelines were also posted on social media but
were not part of the clinical trial. In total, there were anywhere
from 2 to 7 separate posts on both Facebook and Twitter on a
daily basis. In addition, all posts were reposted the next day at
11 AM and 3 PM using the “ICYMI” moniker (ie, “in case you
missed it”) up to a total of 3 posts. Social media platform-
speciﬁc strategies were used. On Twitter, online interaction
was encouraged by retweeting posts of articles randomized to
social media using the ofﬁcial Circulation Twitter account. To
increase the viewership of Facebook posts, posts were
boosted for 24 hours for a total of $10 for each post using
the following targeted approach: persons aged ≥18 years
designating “cardiology” as an interest and residing in Brazil,
Canada, Colombia, Germany, Egypt, France, the United
Kingdom, Mexico, or the United States. At the beginning of
the trial, Circulation had 46 431 likes on Facebook and 6746
followers on Twitter. By the conclusion of the trial,
the journal had 87 607 likes on Facebook and 10 072
followers on Twitter.
Primary End Point
The primary end point was 30-day page views abstracted
through Circulation’s Google Analytics account, including
abstract, HTML, and PDF page views. The 30-day page views
were selected to be consistent with our prior study5 and
because page views have been shown to correlate ultimately
with citations.6
Secondary End Point
Seven-day page views were selected as a secondary end
point. Data were abstracted similarly to the process described
above.
Statistical Methods
Baseline characteristics were categorized and tabulated and
compared across randomized study arms using the chi-square
test for independence. The primary analysis was an intention-
to-treat analysis comparing 30-day article page views by 2-
sample t test on the log-transformed data. As a secondary
analysis, log-transformed 7-day page views by treatment
status were examined.
Prespeciﬁed subgroup analyses included article type
(population, clinical, basic), US versus non-US corresponding
author, editorial (yes, no), and trimester of publication (ﬁrst:
January to April; second: May to August; third: September to
December). The goal of these analyses was to assess the
Overall Study Design
n=192 
original articles 
published during the 
study period
Jan 2015- Sept 2015Exclusions:
AHA Press release 
Circ Author Profile 
n=152 papers randomized (79%)
Social Media
n=74
No Social Media
n=78
Journal publishes an issue every Monday
Social media posts occur Monday-Thursday 
7-day page views from time of publication
30-day page views from time of publication
Figure 1. Schematic of the overall study design. AHA indicates
American Heart Association; Circ, Circulation.
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consistency of the differences between the 2 randomized
study arms within these various subgroups; it was not
necessarily expected that a signiﬁcant difference between the
2 randomized groups would be found within any subgroup
category. Consistency was assessed using logistic regression
on the log of page views with the model containing the
effects of the randomized treatment arm, subgroup (eg, US
versus non-US corresponding author), and randomized
treatment-by-subgroup interaction and rank ANCOVA.
Based on prior power calculations, the mean number of
30-day page views in the control group was assumed to be
525, with a standard deviation of 265, and the distribution
of 30-day page views was assumed to be log-normal. In
addition, we performed a pilot study comparing 7-day page
views of manuscripts boosted with Facebook advertisements
compared with manuscripts with posts on Facebook without
ads. We observed that the number of 7-day page views was
463 in the boosted group compared with 362 in the control
group, a 22% difference. Assuming a sample size of 119
papers in each group and a log-normal distribution for 30-
day page views, a relative improvement for the intervention
group of 22% could be detected at 80% power, and a relative
improvement of 19% could be detected at 90% power, using
a 2-sided a=0.05. An interim look at the data was planned
at the point at which 50% of the manuscripts were
randomized and had 30-day follow-up (“50% information
time”). Termination of the trial was planned if there was
evidence of either futility or overwhelming efﬁcacy. Specif-
ically, at the 50% information time, groups were compared
on 30-day page views using signiﬁcance levels based on the
O’Brien-Fleming stopping philosophy7: (1) If a 1-sided P value
(assessing beneﬁt of social media over no social media) is
<0.00153, then the study may be stopped for overwhelming
efﬁcacy; (2) if a 1-sided P value (assessing beneﬁt of social
media over no social media) is >0.50041, then the study
may be stopped for futility; (3) if the conditional power for a
signiﬁcant beneﬁcial social media effect by the end of the
study is between 50% and 80%, a sample size increase may
be undertaken to maintain 80% conditional power by the end
of the study (the methodology used followed that of Chen
et al,8 which allows an increase in sample size while
maintaining type I error at the nominal level); (4) otherwise,
the study may continue as is. To account for the a level
spent at the interim look, at the ﬁnal assessment
(should the study not be stopped at the interim analysis),
the ﬁnal signiﬁcance level used to test the beneﬁt of
social media over no social media was 0.02481 (1-sided) or
0.04962 (2-sided).
Based on the stopping criteria, the trial was stopped
September 26, 2015. At that time, 123 manuscripts (52%
information) had been randomized and had 30-day follow-up
(61 to the control group and 62 to the intervention arm),
resulting in a change to the P value stopping criteria for
futility to 1-sided P=0.49. The median number of 30-day
page views using the data set at a 52% information time
was 459 in the control group and 486 in the intervention
arm. The 1-sided P value comparing treatment on the log of
30-day page view was 0.49. In addition, the mean
difference between treatments was approximately half of
what was expected, and the standard deviation was
approximately twice as large as expected in the sample
size calculations.
All P values presented are 2-sided. Analyses were carried
out using SAS version 9.4 (SAS Institute).
Results
Overall, 152 manuscripts were randomized: 74 to the social
media arm and 78 to the control arm. A Kolmogorov–Smirnov
test of the data to the log-normal distribution indicated that
the distribution was log-normal within the control and
intervention arms (P≥0.10). As shown in Table 1, there were
no differences in manuscript characteristics between the 2
arms with respect to article type (P=0.85), geographic
Table 1. Study Sample Characteristics by Trial Arm
Social Media
Arm (n=74)
No Social Media
(n=78)
P Value
(Chi-Square Test)
Article type (%)
Clinical 32 (50.8) 31 (49.2) 0.85
Basic 24 (49.0) 25 (51.0)
Population 18 (45.0) 22 (55.0)
Corresponding author (%)
US 40 (52.6) 36 (47.4) 0.33
Non-US 34 (44.7) 42 (55.3)
Date of publication (%)
First third 37 (50.0) 37 (50.0) 0.93
Second third 29 (46.8) 33 (53.2)
Third third 8 (50.0) 8 (50.0)
Editorial (%)
Yes 29 (50.0) 29 (50.0) 0.80
No 45 (47.9) 49 (52.1)
Day of social media post (%)
Monday 26 (100) NA NA
Tuesday 31 (100)
Wednesday 13 (100)
Thursday 3 (100)
Data shown as number with percentages in parentheses for dichotomous data. NA
indicates not available.
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location of the corresponding author (P=0.33), date of
publication (P=0.93), or whether the manuscript had an
editorial (P=0.80).
Median number of 30-day page views was 499.5 in the
intervention arm and 450.5 in the control arm (Table 2). The
cumulative distribution of 30-day page views over the course
of the entire study is shown in Figure 2. There was no
difference in the social media group compared with the
control group (P=0.38). In prespeciﬁed subgroup analyses
(Figure 3), there were no signiﬁcant interactions of subgroups
with treatment (Pinteraction>0.20 for all subgroups). Power,
however, is generally low for assessment of interaction, and
no conclusion of lack of subgroup effect on social media
effect size can truly be made. Although the treatment-by-
publication trimester interaction, for example, was not
signiﬁcant (P=0.31), social media largely improved 30-day
page views in trimester 3 (median improvement of 129 views)
but was detrimental in trimester 2 (median worsening of 41
views). Further studies would be required to assess whether a
true interaction existed in this case.
Examining 7-day page views (Table 3), there was similarly
no difference in number of page views in the social media
group (330.5) compared with the control group (268; P=0.17).
Overall study sample characteristics by 30-day page views
are presented in Table 4. As expected, clinical papers had
more 30-day page views than basic science or population
papers (P<0.0001). No other differences were observed
across study sample characteristics.
Table 5 provides an overview of demographic characteris-
tics from Facebook, Twitter, and Google Analytics for the
Circulation website.
Discussion
In this randomized trial of social media exposure of original
articles published in Circulation from January 2015 through
September 2015, there was no difference in 30-day page
views despite increased intensity of social media delivered to
the intervention arm. The trial was stopped early due to
futility, and no differences were observed in prespeciﬁed
subgroup analyses.
These ﬁndings are largely consistent with our prior
ﬁndings, in which we failed to show increased 30-day page
views among original articles randomized to social media
compared with control.5 These ﬁndings increase the gener-
alizability of our prior ﬁndings to social media campaigns with
more modestly sized followings. To expand on this point, our
prior study was limited by a relatively low intensity of social
media use, as demonstrated by our small following at study
initiation and completion (Facebook had 16 215 likes at
initiation and 28 177 at completion; Twitter had 2219
Table 2. Page Views at 30 Days: Overall and Stratiﬁed by Study Sample Characteristics
Social Media Arm No Social Media
P Value* Assessing Interaction of
Treatment and SubgroupMean (SD) Median (25th/75th) Mean (SD) Median (25th/75th)
Overall 616.0 (367.0) 499.5 (375/767) 597.2 (450.8) 450.5 (321/754) NA
Article type
Clinical 821.5 (437.8) 700 (521.5/1047) 813 (576.0) 635 (438/1000) 0.96
Basic 379.6 (111.0) 392.5 (309/466) 339.9 (98.0) 334 (255/387)
Population 565.8 (226.1) 507 (377/626) 585.4 (335.6) 495 (339/762)
Corresponding author
US 632.4 (385.1) 512 (392/782) 510.0 (304.1) 448.5 (286.5/572) 0.21
Non-US 596.7 (349.2) 489.5 (341/600) 671.8 (538.9) 450.5 (339/772)
Date of publication
First third 643.9 (445.4) 473 (362/650) 493.3 (305.3) 392 (310/525) 0.20
Second third 601.9 (296.2) 500 (396/872) 744.0 (578.5) 565 (376/923)
Third third 537.8 (146.8) 543.5 (466/621.5) 471.8 (223.9) 395.5 (303/609)
Editorial
Yes 686.8 (435.8) 524 (388/853) 653.3 (501.8) 459 (380/754) 0.77
No 570.4 (311.7) 483 (373/626) 563.9 (419.7) 387 (281/635)
Overall P value of treatment vs control: 0.38. NA indicates not available.
*P values based on log-page views.
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followers at initiation and 4758 at completion). In contrast,
the present study had nearly 4 times as many users following.
In addition, strategies were used to increase the reach of
social media, including posting in triplicate, tweeting, and
boosting posts using the Facebook advertising function.
Despite this, the study remained unable to demonstrate
differences in 30-day page views between the 2 arms.
Consequently, the generalizability of these ﬁndings can be
applied to the majority of medical journal social media
campaigns, which have following bases of similar magnitude
to that in the present study.
Our prior ﬁndings have been criticized by others using
social media to promote medical journal content. Thoma
et al,9 for example, cited their experience with the Annals of
Emergency Medicine, for which they created a comprehen-
sive social media campaign that was associated with an
increase in trafﬁc to the website annemergmed.com of 289%
compared with the prior calendar year. Although this
increase is impressive, it is an ecological association, and
attribution to the social media campaign cannot be deter-
mined based on the observational design. Dixon et al10 cited
their experience with a blog post on Radiopaedia.org
regarding a manuscript published in PLoS One.11 Following
the blog post and sharing on Facebook, article views
increased from 3234 to 6768 in the 7 days following the
posting. Aase’s blog piece on our prior work highlighted that
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Figure 2. Cumulative distribution of page views overall and by manuscript type: (A) the overall sample, (B) basic science papers, (C) clinical
papers, and (D) population science papers. SM indicates social media.
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good science is not always consistent with good communi-
cation and that page views do not convey the full impact of
social media.12 Finally, Djuricich and Madanick13 cited our
own experience of the virality of our prior study (1.5 million
accounts reached on Twitter within 1 week of publishing our
paper) as evidence of the power of social media. Although
impressive, these anecdotes cannot be generalized to
ﬁndings from a randomized control trial that exposes
randomly selected manuscripts to social media instead of
carefully selected papers that are featured on social media
because they are deemed to have high impact.
Our ﬁndings are supported by a recent observational study
that examined the impact of social media dissemination and
implementation of clinical practice guidelines and failed to
show a beneﬁt with social media dissemination based on
clinical practice guideline knowledge or behavioral change
compared with print, email, or Internet-based materials.14
Taken together, these ﬁndings highlight the need to
develop new metrics of quantifying value for social media
campaigns developed by medical journals. These ﬁndings
highlight that, for original research, counting page views is not
a meaningful metric. Metrics to be considered in the future
may include brand recognition, community building, and
knowledge assessments, although the methods in which they
can ultimately be quantiﬁed may require development. In
addition, these ﬁndings highlight that high-impact papers can
15
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Figure 3. Forest plots displaying the results by trial arm in the
overall study and by subgroups. SM indicates social media.
Table 3. Page Views at 7 Days: Overall and Stratiﬁed by Study Sample Characteristics
Social Media Arm No Social Media
P Value* Assessing Interaction of
Treatment and SubgroupMean (SD) Median (25th/75th) Mean (SD) Median (25th/75th)
Overall 397.4 (243.7) 330.5 (234/445) 359.1 (242.5) 268 (196/433)
Article type
Clinical 533.8 (282.4) 432 (351/648.5) 475.5 (287.4) 391 (260/682) 0.86
Basic 230.6 (67.9) 233.5 (192.5/265) 197.2 (65.5) 178 (141/249)
Population 377.2 (169.1) 338.5 (279/378) 379.2 (202.5) 341.5 (225/518)
Corresponding author
US 405.6 (248.4) 345.5 (235/486.5) 318.7 (185.5) 258 (177/368.5) 0.35
Non-US 387.7 (241.4) 307.5 (233/435) 393.8 (279.9) 280.5 (201/518)
Date of publication
First third 405.4 (287.7) 279 (227/398) 304.7 (192.8) 246 (161/350) 0.34
Second third 404.9 (209.7) 347 (253/585) 438.5 (291.7) 367 (210/526)
Third third 333.0 (111.7) 336 (285/380.5) 283.6 (121.2) 279 (177/395)
Editorial
Yes 442.0 (291.8) 347 (253/604) 382.1 (233.0) 313 (243/433) 0.79
No 368.6 (205.4) 319 (234/429) 345.6 (249.3) 256 (156/424)
Overall P value of treatment vs control: 0.17.
*P values based on log-page view.
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be identiﬁed using early social media metrics, but papers
cannot be made high impact through social media promotion.
A similar argument has been made for the citation
index of individual papers: Although publication in a
high-impact journal might give a manuscript an early boost,
in time, the scientiﬁc community tends to recognize important
work regardless of target journal publication.15
Strengths of this study include the rigorous clinical trial
design that was adequately powered for our primary
outcome (30-day page views). The primary outcome was
objective and unbiased between the control and intervention
arms. Some limitations warrant mention. The intervention
was delivered solely to original articles; these ﬁndings are
not generalizable to review articles, clinical practice guide-
lines, clinician updates, and other content that is frequently
delivered on social media and in medical journals. The
primary outcome, although easily quantiﬁable, does not
reﬂect the complexity of social media dissemination.
Furthermore, the trial was stopped early due to futility;
therefore, ﬁndings are likely underpowered for prespeciﬁed
analyses other than our primary outcome. Whereas our
primary analysis focused on 30-day page views, our 7-day
page view analysis suggested more granularity in ﬁndings
that were more proximal to publication. Tweets are known to
follow a Pareto distribution, with the majority occurring
within the ﬁrst 2 days of publication1; however, we were
more interested in the longer term impact of social media
and intentionally designed our study to focus on 30-day
page views and not a more proximal end point. We powered
our study to achieve a 22% improvement in the social media
arm, reﬂecting a trial design that would be feasible
compared with powering for a lower treatment difference
(eg, a 10% difference would require a 3-year study). It is
possible that smaller differences would be observable with a
longer term study. Finally, although our follower base was 4
times larger than that in our prior clinical trial, it was still
relatively modest. It is unclear if these ﬁndings are
generalizable to medical journals with larger followings.
A more intensive social media strategy did not result in
increased 30-day page views of original research. Novel
metrics of return on investment of social media strategies are
required.
Table 4. Overall Study Sample Characteristics for 30-Day Page Views
Mean (SD) Median (25th/75th)
P Value for Within-Group
Comparison
Article type
Clinical 817.3 (506.3) 635 (489/1039) <0.0001
Basic 359.3 (105.4) 362 (292/443)
Population 576.6 (288.2) 503 (361/704.5)
Corresponding author
US 574.4 (352.2) 478.5 (342.5/650.5) 0.41
Non-US 638.2 (462.4) 481 (339.5/767)
Date of publication
First third 568.6 (386.7) 440.5 (321/596) 0.24
Second third 677.5 (470.0) 551 (376/874)
Third third 504.8 (186.1) 485.5 (327/621.5)
30-day page views 606.3 (410.9) 478.5 (339.5/756) NA
Editorial
Yes 670.0 (466.1) 499.5 (380/813) 0.07
No 567.0 (370.0) 468.5 (310/633)
Day of social media post
Monday 692.0 (452.9) 553 (420/650) 0.40
Tuesday 570.7 (286.1) 470 (335/853)
Wednesday 635.0 (389.2) 483 (388/767)
Thursday 374.0 (119.5) 362 (261/499)
NA indicates not available.
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Table 5. User Statistics From the Circulation Facebook and Twitter Feed and Overall Circulation Website Trafﬁc
Demographic Information Facebook Twitter Circulation Website Analytics
Gender (%)
Women 38 32 52.8
Men 61 68 47.2
Age, y (%)
13 to 17 0.9 NA —
18 to 24 32 22.5
25 to 34 40 27.7
35 to 44 14 15.0
45 to 54 7 11.5
55 to 64 3 12.5
≥65 1.8 10.8
Country (%) Egypt, 19.9 United States, 31 United States, 46.4
India, 16.4 Spain, 11 United Kingdom, 8.4
Mexico, 8.9 United Kingdom, 6 Canada, 5.0
United States, 6.7 Mexico, 5 India, 4.2
Brazil, 4.9 Canada, 3 Japan, 2.4
Colombia, 4.1 Italy, 3 Australia, 2.3
Pakistan, 2.7 Australia, 3 China, 1.9
Thailand, 1.7 Argentina, 3 Germany, 1.8
Italy, 1.5 Colombia, 3 Italy, 1.4
Saudi Arabia, 1.2 Saudi Arabia, 2 Thailand, 1.0
Data obtained January 9, 2016, from Facebook and Twitter and January 16, 2016, from Google Analytics. NA indicates not available.
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